Full-Time

Head of Global MSAT

Posted on 1/30/2023

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Accelerates antibody drug discovery with data science

Data & Analytics
AI & Machine Learning
Biotechnology

Senior, Expert

Vancouver, BC, Canada

Requirements
  • You are strongly self-motivated and are able to identify project needs and follow that up with building and implementing solutions
  • You are passionate about building dynamic new teams and capabilities that accomplish important goals
  • You have a bias towards innovation over industry standards
  • You are enthusiastic about applying your expertise in manufacturing operations
  • You are an outstanding communicator and teammate
  • 12+ years of experience in PD, MSAT or manufacturing of biologics in a GMP setting; experience with mAbs highly preferred
  • 6+ year of experience leading a team within a biotechnology or pharmaceutical organization
  • Outstanding technical acumen, operational understanding, and a deep understanding of manufacturing functions is desirable
  • Strong leadership passion to build, lead, and mentor a team with the opportunity to leave a lasting legacy on the team, the organization, and the country
  • A desire to innovate and push to do things differently
  • Strong communication, teamwork and relationship building skills across the organization
  • The ability to apply pragmatic, risk-based decision making to the operation
  • Strong ability to be strategic
  • Experience leading a site through Quality audits and/or regulatory inspections
  • Experience with CMC regulatory filings
  • A BS/MS/PhD in Biological Sciences or Engineering

AbCellera stands out as a leader in the biotech industry due to its unique approach to antibody drug discovery, combining expert teams, advanced technology, and data science to expedite the process from target to clinic across various therapeutic areas. The company's competitive edge lies in its ability to enable swift progress, cost reduction, and problem-solving in drug development for both innovative biotechs and leading pharmaceutical companies. Furthermore, AbCellera's commitment to technical innovation is evident in its recent presentation of new data on two T-Cell Engager Programs at SITC 2023, demonstrating its active role in advancing the field.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

16%

2 year growth

77%
INACTIVE